Fournier's Gangrene

Topic Overview

Summary

Fournier's gangrene is a rare but life-threatening form of necrotising fasciitis affecting the perineum, genitalia, and perianal region. It represents a surgical emergency requiring immediate recognition and aggressive management. The condition is characterised by polymicrobial infection causing rapid tissue destruction along fascial planes, with mortality rates ranging from 20-40% despite modern treatment. [1,2] Early surgical debridement within 24 hours of presentation, combined with broad-spectrum antibiotics and intensive care support, is critical for survival. Delay in diagnosis or surgical intervention dramatically increases mortality. [3]

Key Facts

• Definition: Type I necrotising fasciitis of perineum, scrotum, and genitalia
• Mortality: 20-40% overall; up to 80% if diagnosis delayed > 24 hours [1,2]
• Microbiology: Polymicrobial (average 3-5 organisms) - synergistic aerobic + anaerobic infection [4]
• Key feature: Rapid spread along Colles', Scarpa's and dartos fascia
• Pathognomonic sign: Pain out of proportion to examination findings
• Treatment: IMMEDIATE surgical debridement + broad-spectrum IV antibiotics + ICU support
• Time-critical: Every hour delay increases mortality by 7.6% [3]

Clinical Pearls

Fournier's gangrene IS necrotising fasciitis — it's simply the anatomical location (perineum) that defines it. Same pathophysiology, same urgency, same principles.

Pain out of proportion to examination is the earliest and most important clinical clue. Do NOT wait for skin necrosis or crepitus — these are late signs.

The LRINEC score (Laboratory Risk Indicator for Necrotizing Fasciitis) ≥6 has 92% sensitivity for necrotising soft tissue infections and should prompt urgent surgical consultation. [5]

FGSI score > 9 predicts 75% mortality; score ≤9 predicts 78% survival. However, scoring should NEVER delay surgery. [6]

CT imaging should NOT delay surgery if clinical suspicion is high. Diagnosis is primarily clinical. Imaging is helpful when diagnosis uncertain but NOT mandatory when clinical signs obvious.

Testes and penis are typically spared because they have a separate blood supply (testicular artery from aorta). If these structures are involved, consider alternative diagnoses.

Multiple debridements are the rule, not the exception. Patients typically require 3-5 operations. Return to theatre every 24-48 hours until healthy tissue margins achieved. [7]

Why This Matters Clinically

Fournier's gangrene is one of the few true surgical emergencies where immediate recognition and action directly determine survival. A 50-year-old diabetic male presenting to Emergency Department at 2pm with severe perineal pain and minimal examination findings may be dead by midnight without surgical debridement. The condition progresses with alarming rapidity — skin that appears viable at initial assessment may be necrotic within 6 hours. Early intervention saves lives; delay is often fatal. Every doctor in emergency medicine, general practice, urology, and general surgery must be able to recognise this condition immediately.

---

Visual Summary

Visual assets to be added:

• Fournier's gangrene clinical progression timeline (hours 0-72)
• Anatomical spread pathways: Colles', Scarpa's, and dartos fascia
• FGSI and LRINEC scoring tables with mortality correlation
• Management algorithm: recognition → resuscitation → debridement → reconstruction
• Serial debridement wound evolution (operative photographs)
• Polymicrobial synergy concept diagram

---

Epidemiology

Incidence

Demographics

Risk Factors

Major Risk Factors (Present in 80-95% of Cases)

Other Significant Risk Factors

Iatrogenic/Procedural Triggers

• Urethral catheterisation or instrumentation
• Anorectal surgery or procedures
• Circumcision
• Penile prosthesis surgery
• Inguinal hernia repair
• Haemorrhoidectomy
• Perineal trauma (sexual, accidental, surgical)

Sources of Infection

---

Pathophysiology

Mechanism of Tissue Destruction

Fournier's gangrene is a Type I necrotising fasciitis — polymicrobial synergistic infection causing rapid fascial and tissue necrosis.

Pathophysiological Cascade

1. Initiating Event

• Breach of skin/mucosal barrier (trauma, surgery, infection)
• Introduction of polymicrobial inoculum into perineal tissues
• Often involves communication between GI/GU tract and soft tissues

2. Bacterial Synergy (Critical Concept)

• Aerobic organisms (E. coli, Klebsiella, Enterococci) consume oxygen → tissue hypoxia
• Anaerobic organisms (Bacteroides, Clostridium, Peptostreptococcus) thrive in hypoxic environment
• Synergistic toxin production enhances bacterial virulence
• Combined effect exceeds sum of individual organisms

3. Microvascular Thrombosis

• Bacterial toxins → obliterative endarteritis
• Small vessel thrombosis → tissue ischaemia
• Progressive ischaemia → tissue necrosis
• Creates ideal environment for anaerobic proliferation (vicious cycle)

4. Fascial Spread

• Infection spreads rapidly along fascial planes (path of least resistance)
• Dartos fascia (scrotum) → Colles' fascia (perineum) → Scarpa's fascia (anterior abdominal wall)
• Can extend to thighs, buttocks, anterior abdominal wall
• Subcutaneous tissue and skin supplied by perforators from deeper vessels → skin necrosis follows fascial involvement

5. Systemic Toxicity

• Massive bacterial load → overwhelming sepsis
• Cytokine storm → SIRS/septic shock
• Multi-organ dysfunction syndrome (MODS)
• Disseminated intravascular coagulation (DIC)

Microbiology — Polymicrobial Infection

Average: 3-5 organisms per patient [4]

Aerobic Organisms (50-80% of cultures)

Anaerobic Organisms (80-95% of cultures)

Rare but Important Organisms

• Candida spp. — in immunocompromised (5-10%)
• Group A Streptococcus — aggressive, toxin-mediated (monomicrobial variant)
• Vibrio vulnificus — marine exposure, very high mortality

Anatomical Spread Patterns

Key Fascial Planes

Extent of Spread (at Presentation)

Structures Typically Spared

• Testes — separate blood supply (testicular artery from aorta)
• Spermatic cord — separate fascial compartment
• Deep penile structures — Buck's fascia provides barrier
• If these ARE involved → consider alternative diagnosis (primary genital malignancy, etc.)

---

Clinical Presentation

Temporal Evolution

HOUR 0-12 (Early — Easily Missed)

• Perineal/scrotal discomfort or pain
• Fever, malaise
• Pain out of proportion to physical findings (CRITICAL EARLY SIGN)
• Minimal skin changes or normal examination
• Often dismissed as cellulitis, abscess, or UTI

HOUR 12-24 (Established)

• Increasing pain despite analgesia
• Scrotal/perineal swelling and oedema
• Erythema with ILL-DEFINED margins (key feature)
• Systemic toxicity (fever, tachycardia, confusion)
• Tenderness extending beyond visible erythema

HOUR 24-48 (Advanced — Do NOT Wait for These Signs)

• Skin necrosis (black/purple/grey discolouration)
• Haemorrhagic bullae
• Crepitus (palpable subcutaneous gas)
• Foul-smelling discharge
• Rapid spread (can advance 2-3 cm per hour)
• Septic shock

> 48 HOURS (Critical)

• Extensive tissue loss
• Multi-organ failure
• DIC
• Very high mortality (> 60%) [3]

Cardinal Symptoms

Physical Examination Findings

Early Signs (High Index of Suspicion Required)

Established Signs

Systemic Examination

Focused Perineal Examination

Inspection

• Extent of erythema (document with photographs and measurements)
• Skin changes (colour, necrosis, bullae)
• Discharge (purulent, serosanguinous, faecal)
• Urethral meatus (discharge, injury)

Palpation

• Crepitus (pathognomonic but only in 20-60%)
• Fluctuance (abscess)
• Extent of induration
• Testicular examination (sparing suggests FG; involvement suggests other pathology)

Digital Rectal Examination (ESSENTIAL)

• Identifies anorectal source (abscess, fistula, mass)
• Assesses sphincter tone
• May need examination under anaesthesia

Red Flags — Immediate Surgical Consultation

---

Clinical Examination

Systematic Approach

A-E Assessment (Emergency Presentation)

Severity Assessment Tools

LRINEC Score (Laboratory Risk Indicator for Necrotizing Fasciitis) [5]

Interpretation:

• Score ≥6: High risk for necrotising fasciitis (92% sensitivity, 96% specificity) [5]
• Score 6-7: Intermediate risk (50% probability)
• Score ≥8: High risk (> 75% probability)

IMPORTANT: LRINEC should SUPPORT but NEVER delay surgical decision-making. Clinical suspicion trumps scoring.

FGSI (Fournier's Gangrene Severity Index) [6]

Includes: Temperature, heart rate, respiratory rate, sodium, potassium, creatinine, haematocrit, WBC, bicarbonate

Interpretation:

• Score ≤9: 78% survival
• Score > 9: 75% mortality

Limitations:

• Retrospective prognostication, NOT diagnostic
• Should NOT delay surgical intervention
• Useful for family counselling and ICU resource planning

---

Investigations

Emergency Investigations (Within 1 Hour)

Blood Tests

LRINEC Score Calculation

• Calculate IMMEDIATELY on blood results
• Score ≥6 → high suspicion → urgent surgical consult
• Score less than 6 does NOT exclude diagnosis if clinical suspicion high

Microbiological Investigations

Imaging

CRITICAL PRINCIPLE: Do NOT delay surgery for imaging if diagnosis clinically obvious.

Plain X-Ray (Scrotum/Perineum)

Utility: Low; rarely changes management; historical interest.

CT Pelvis with IV Contrast (Gold Standard Imaging) [10]

Indications for CT:

• Diagnosis uncertain on clinical grounds
• Patient stable enough for scan
• Planning surgical approach (extent)
• Identifying underlying source (anorectal, GU)

DO NOT perform CT if:

• Clinical diagnosis clear (crepitus + necrosis)
• Patient too unstable to leave resuscitation area
• Would delay surgery by > 30 minutes

Ultrasound (Bedside)

Advantages: Bedside, rapid, no radiation Limitations: Operator-dependent, limited field of view

MRI

Not recommended in acute setting (time-consuming, limited availability, patient too unstable)

Source Identification Investigations

---

Diagnosis

Clinical Diagnosis (Primarily Clinical)

Fournier's Gangrene Should Be Suspected in ANY Patient with:

1. Perineal/scrotal pain + systemic toxicity
2. Pain out of proportion to examination findings
3. Risk factors (diabetes, immunosuppression, recent GU/anorectal procedure)
4. Rapidly progressive perineal cellulitis

Diagnosis CONFIRMED by:

• Clinical findings (crepitus + necrosis = pathognomonic)
• OR LRINEC score ≥6 + clinical suspicion
• OR CT showing gas + fascial thickening
• Ultimately: Intraoperative findings and histopathology

Differential Diagnosis

RED FLAG FEATURES favouring Fournier's over cellulitis:

• Pain out of proportion
• Crepitus
• Rapid spread (hours)
• Skin necrosis
• Systemic toxicity despite antibiotics
• LRINEC ≥6

---

Classification & Staging

By Microbiological Type

By Anatomical Source

By Extent (Surgical Staging)

---

Management

Overview — Three Pillars

1. IMMEDIATE SURGICAL DEBRIDEMENT (life-saving intervention)
2. Broad-spectrum IV antibiotics (adjunct to surgery)
3. Intensive care support (resuscitation, organ support)

CRITICAL PRINCIPLE: Time to surgery is THE most important determinant of survival. Every hour delay increases mortality by 7.6%. [3]

---

Phase 1: Resuscitation (First 60 Minutes)

Immediate Actions (Parallel Processing)

Specific Resuscitation Goals

Antibiotics — Broad-Spectrum Polymicrobial Coverage

START WITHIN 1 HOUR (but do NOT delay surgery for antibiotics)

Recommended Regimens:

Why Clindamycin?

• Suppresses toxin production (exotoxins from Strep/Staph)
• Anaerobic coverage
• Maintains efficacy in stationary-phase bacteria (not growth-dependent)

Duration:

• Continue until NO further debridement needed + afebrile 48h + clinically improving
• Typically 7-14 days total
• Adjust based on intraoperative cultures

ICU Referral (IMMEDIATE)

Indications for ICU:

• Septic shock
• Lactate > 4 mmol/L
• Multi-organ dysfunction
• Extensive disease
• Post-operative monitoring after major debridement

---

Phase 2: Emergency Surgical Debridement (LIFE-SAVING)

TIME TO SURGERY = SURVIVAL

Surgical Principles

1. Adequate Debridement (CRITICAL)

• Remove ALL necrotic tissue — extends well beyond visible necrosis
• Debride to bleeding, healthy tissue ("when it bleeds, it's alive")
• Do NOT worry about cosmesis — preservation of life > preservation of anatomy
• Necrotic fascia, subcutaneous tissue, skin ALL excised
• Send deep tissue (NOT swabs) for culture (aerobic + anaerobic)

2. Source Control

• Identify and manage underlying source:
  • "Anorectal: Abscess drainage, defunctioning colostomy if extensive"
  • "Genitourinary: Urethral catheter or suprapubic catheter"
  • "Rectal perforation: Hartmann's procedure"
• Drain all abscesses
• Excise fistulous tracts

3. Urinary and Faecal Diversion

Faecal diversion improves wound healing and reduces mortality. [11]

4. Testicular Handling

• Testes typically viable (separate blood supply)
• Excise necrotic scrotal skin
• Place exposed testes in subcutaneous thigh pouches OR leave in open wound (cover with dressings)
• Orchidectomy ONLY if testis non-viable

5. Wound Management

• Leave wound OPEN (no primary closure)
• Pack loosely with saline-soaked gauze OR negative pressure wound therapy (NPWT/VAC)
• DO NOT close under tension

Anaesthetic Considerations

Intraoperative Findings (Diagnostic Confirmation)

• Necrotic fascia ("dishwater grey", non-bleeding)
• Lack of bleeding from debrided tissue
• Foul smell
• Easy separation of tissues (finger dissection along planes)
• "Dishwater pus" (thin, grey, seropurulent)

---

Phase 3: Serial Debridements (The Rule, Not the Exception)

Second-look laparotomy is MANDATORY

Why Multiple Debridements?

• Tissue that appears viable at first operation may become necrotic
• Infection often progresses despite initial debridement
• Inadequate initial debridement is a major cause of death

---

Phase 4: Intensive Care Support

Organ Support

Nutritional Support

• Early enteral nutrition (NG feeding if tolerated)
• High protein requirement (extensive wounds, catabolism)
• Involve dietician
• TPN if enteral not tolerated

Wound Care

NPWT is preferred in most cases.

Adjunctive Therapies (Controversial)

No adjunct replaces adequate surgical debridement.

---

Phase 5: Reconstruction (Weeks to Months Later)

Timing: Once infection FULLY controlled (may be 4-12 weeks)

Wound Healing Options

Common Reconstructive Techniques

Testicular Management

• If testes placed in thigh pouches → return to scrotum (scrotal reconstruction or prosthetic scrotum)
• Orchidopexy once scrotal reconstruction complete

---

Monitoring and Follow-Up

Acute Phase Monitoring

Long-Term Follow-Up

• Plastic surgery (reconstruction planning)
• Urology (testicular function, erectile function assessment)
• Psychology (PTSD, body image, sexual dysfunction)
• Diabetes/endocrinology (optimise glycaemic control)

---

Complications

Acute Complications (During Hospital Stay)

Wound Complications

Subacute/Chronic Complications

---

Prognosis & Outcomes

Mortality

Overall Mortality: 20-40% (despite modern ICU care) [1,2]

Prognostic Factors

Poor Prognostic Factors (Increased Mortality)

Favourable Prognostic Factors

Functional Outcomes (Survivors)

Quality of Life

• Significant physical and psychological morbidity
• Sexual dysfunction major concern for many survivors
• Body image issues
• Support groups and psychology referral beneficial

---

Prevention

Primary Prevention

Secondary Prevention (Reduce Progression)

• Early recognition and referral (primary care, ED)
• Low threshold for imaging if diagnostic uncertainty
• Urgent surgical consultation if LRINEC ≥6 or high clinical suspicion

Tertiary Prevention (Reduce Recurrence)

• Treat underlying source (fistula repair, urethral stricture management)
• Optimise diabetes
• Address immunosuppression (if modifiable)

---

Evidence & Guidelines

Landmark Studies

1. Eke N. Br J Surg 2000 — Systematic review of 1,726 cases; mortality 20-40%; established key epidemiology [PMID: 10848848]
2. Laor E et al. J Urol 1995 — FGSI score development and validation [PMID: 7776464]
3. Sorensen MD et al. J Urol 2009 — Time to surgery critical; each hour delay increases mortality 7.6% [PMID: 19375090]
4. Wong CH et al. Crit Care Med 2004 — LRINEC score development for necrotising fasciitis [PMID: 15286537]
5. Singh A et al. Eur Urol Focus 2019 — Modern comprehensive review [PMID: 29042201]

Key Evidence Points

Guidelines

No Specialty-Specific Guideline Exists for Fournier's Gangrene

Management based on:

• General necrotising fasciitis principles
• Expert consensus
• Large case series
• Surgical emergency protocols

Relevant Guidelines:

• IDSA Guidelines on Skin and Soft Tissue Infections (general principles)
• Surviving Sepsis Campaign (septic shock management)
• WSES Guidelines on Necrotising Fasciitis (general necrotising infections)

---

Special Populations

Female Patients (3-10% of cases) [9]

• Sites: Vulva, perineum, perianal region
• Sources: Bartholin abscess, episiotomy infection, vaginal trauma, vulvar surgery
• Mortality: Similar to males
• Management: Same principles (aggressive debridement)

Paediatric Patients (Rare)

• Aetiology: Often circumcision-related, omphalitis (neonates), perianal abscess
• Mortality: Lower than adults (10-20%) if treated promptly
• Management: As adults; involve paediatric surgery

Immunocompromised (HIV, Transplant, Biologics)

• Increased risk: 2-4 fold
• Atypical organisms: Candida, atypical mycobacteria
• Worse outcomes: Higher mortality
• Management: Broaden antimicrobial coverage; consider antifungals

Diabetics (40-60% of patients)

• Key challenge: Hyperglycaemia impairs immunity and wound healing
• Management: Aggressive glucose control (target 6-10 mmol/L); insulin infusion initially
• Complications: Higher risk of AKI, longer hospital stay

---

Patient & Family Information

What is Fournier's Gangrene?

Fournier's gangrene is a very serious and rare infection affecting the skin and tissues around the genital area and bottom (perineum). It is a type of "flesh-eating" bacterial infection that spreads very quickly and can be life-threatening. The infection destroys skin, fat, and the layers beneath the skin.

What Causes It?

The infection is caused by bacteria (usually several types working together). It can start from:

• A small injury or cut in the genital area
• An abscess (collection of pus) near the bottom
• A urine infection that spreads
• After surgery or medical procedures in that area
• Sometimes no clear cause is found

Who is at Risk?

People more likely to get Fournier's gangrene include:

• People with diabetes
• People with weakened immune systems
• Older adults
• People who drink a lot of alcohol
• People who have had recent surgery or injury in the genital/bottom area

What are the Symptoms?

Early symptoms (SEEK HELP IMMEDIATELY):

• Severe pain in the genital area or bottom
• Swelling and redness
• High fever
• Feeling very unwell
• Pain that seems worse than what the doctor can see

Later symptoms (EMERGENCY):

• Skin turning black or purple
• Blistering
• Foul-smelling discharge
• Feeling confused or very drowsy

If you or someone you know has these symptoms, call an ambulance (999/911) immediately. This is a medical emergency.

How is it Treated?

Treatment MUST start immediately and includes:

1. Emergency surgery to remove all dead and infected tissue

   • Usually multiple operations are needed (average 3-5)
   • Surgery may need to happen every 1-2 days initially

2. Strong antibiotics given through a drip (intravenous)

   • Usually several antibiotics together
   • Continue for 1-2 weeks

3. Intensive care (ICU)

   • Help with breathing, blood pressure, and kidney function if needed
   • Close monitoring

4. Wound care

   • Special dressings (often vacuum dressings)
   • Wounds left open initially (cannot be closed until infection cleared)

5. Reconstructive surgery (later)

   • Skin grafts or flaps to close wounds
   • May happen weeks or months after the infection is cleared

What is the Outlook?

Fournier's gangrene is very serious:

• Survival: 60-80% of people survive if treated quickly
• Delay is dangerous: Every hour of delay makes survival less likely
• Hospital stay: Typically 4-8 weeks (sometimes longer)
• Multiple operations: Almost everyone needs 3-5 operations

Long-Term Effects

Survivors may experience:

• Large scars
• Sexual problems (difficulty with erections, sensation changes)
• Urinary problems (difficulty passing urine)
• Psychological effects (PTSD, anxiety, depression)
• Chronic pain

Support is available:

• Counselling and psychology support
• Sexual health specialists
• Support groups
• Reconstructive surgery options

Prevention

To reduce risk:

• Control diabetes carefully
• Good personal hygiene
• Seek early treatment for genital/bottom infections
• Attend regular medical check-ups if you have diabetes or a weak immune system

Questions to Ask Your Doctor

1. How extensive is the infection?
2. How many operations am I likely to need?
3. What are my chances of survival?
4. Will I need intensive care?
5. What will my recovery look like?
6. Will I have long-term effects (sexual, urinary, cosmetic)?
7. What support is available for me and my family?

Resources

• Sepsis Trust: https://sepsistrust.org
• NHS Necrotising Fasciitis Information: https://www.nhs.uk/conditions/necrotising-fasciitis/
• Fournier's Gangrene Support Groups: Ask your hospital for local/online support groups

Emergency Contact

If you have been diagnosed with Fournier's gangrene and develop ANY of the following after leaving hospital, call 999/911 or return to Emergency Department immediately:

• New pain or redness
• Fever
• Foul smell from wound
• Feeling unwell or confused
• Wound breakdown

---

Viva/Exam Scenarios

Scenario 1: Emergency Department Presentation

Stem: A 55-year-old man with type 2 diabetes presents to ED with 24 hours of severe perineal pain and fever. On examination, he is tachycardic (110 bpm), febrile (38.5°C), with scrotal swelling and purple discolouration extending to the perineum. What is your differential diagnosis and immediate management?

Model Answer:

Differential Diagnosis:

• Fournier's gangrene (necrotising fasciitis of perineum) — MOST LIKELY
• Scrotal abscess
• Severe cellulitis
• Testicular torsion (less likely given age and features)

Key Features Suggesting Fournier's:

• Diabetes (major risk factor)
• Severe pain with systemic toxicity
• Purple skin discolouration (necrosis)
• Perineal involvement

Immediate Management (A-E approach):

1. Resuscitation:

   • High-flow oxygen
   • Two large-bore IV cannulae
   • IV fluid resuscitation (1L crystalloid bolus)
   • Analgesia (IV morphine)

2. Investigations:

   • Blood: FBC, CRP, U&E, glucose, lactate, VBG, coagulation, G&S
   • Calculate LRINEC score (if ≥6, high risk necrotising infection)
   • Blood cultures (before antibiotics)
   • Urinalysis

3. Imaging (if diagnosis uncertain, but DO NOT delay surgery):

   • CT pelvis (subcutaneous gas, fascial thickening)

4. Antibiotics (broad-spectrum):

   • Piperacillin-tazobactam 4.5g IV + Clindamycin 600mg IV

5. Urgent Surgical Referral:

   • This is a surgical emergency
   • Inform consultant surgeon immediately
   • Time to surgery is THE critical factor (every hour delay increases mortality 7.6%)
   • Plan for emergency theatre

6. ICU Referral:

   • Alert ICU (likely post-op ICU care required)

Definitive Treatment:

• Emergency surgical debridement (remove all necrotic tissue to bleeding margins)
• Serial debridements (return to theatre every 24-48h)

Key Message: Fournier's gangrene is a time-critical surgical emergency. Do NOT delay surgery for imaging if diagnosis clinically obvious. Early aggressive debridement saves lives.

---

Scenario 2: FGSI and LRINEC Scores

Stem: What scoring systems are used in Fournier's gangrene and what is their utility?

Model Answer:

1. LRINEC Score (Laboratory Risk Indicator for Necrotizing Fasciitis) [5]

Purpose: Differentiate necrotising fasciitis from severe cellulitis

Components (6 parameters):

• CRP (≥150 mg/L: 4 points)
• WBC (less than 15: 0; 15-25: 1; > 25: 2)
• Haemoglobin (> 13.5: 0; 11-13.5: 1; less than 11: 2)
• Sodium (less than 135: 2)
• Creatinine (> 141 μmol/L: 2)
• Glucose (> 10 mmol/L: 1)

Interpretation:

• Score ≥6: High risk (92% sensitivity, 96% specificity for necrotising infection)
• Score 6-7: Intermediate risk
• Score ≥8: High risk (> 75% probability)

Utility:

• Supports diagnosis in uncertain cases
• Prompts urgent surgical referral
• NEVER replaces clinical judgement

2. FGSI (Fournier's Gangrene Severity Index) [6]

Purpose: Predict mortality (prognostic, NOT diagnostic)

Components (9 parameters):

• Vital signs: temperature, heart rate, respiratory rate
• Labs: sodium, potassium, creatinine, haematocrit, WBC, bicarbonate

Interpretation:

• Score ≤9: 78% survival
• Score > 9: 75% mortality

Utility:

• Prognostication (counsel family, ICU resource planning)
• Research stratification
• Does NOT guide decision to operate (all patients need immediate surgery)

Key Point: Neither score should DELAY surgical intervention. Diagnosis is primarily clinical. Use scores to support decision-making, NOT replace it.

---

Scenario 3: Surgical Debridement Principles

Stem: You are the surgical registrar on-call. A patient with confirmed Fournier's gangrene is being taken to theatre. Describe your surgical approach and principles of debridement.

Model Answer:

Pre-operative:

• Inform consultant
• Anaesthetic assessment (high-risk; may need invasive monitoring, vasopressors)
• Consent (high-risk surgery, mortality 20-40%, multiple operations, stoma/urinary diversion possible, reconstruction later)
• ICU bed booked

Surgical Principles:

1. Adequate Debridement (MOST IMPORTANT):

• Remove ALL necrotic tissue to bleeding, healthy margins
• "When it bleeds, it's alive" — debride until viable tissue
• Extends well beyond visible skin necrosis (fascial involvement exceeds skin changes)
• Do NOT worry about cosmesis — LIFE before anatomy

2. Tissue for Microbiology:

• Deep tissue specimens (NOT swabs)
• Aerobic + anaerobic cultures

3. Source Control:

• Identify and treat underlying cause:
  • "Anorectal: Drain abscess, examine for fistula/perforation"
  • "Genitourinary: Assess urethra"
• Digital rectal examination (or EUA proctoscopy)

4. Urinary Diversion:

• Urethral catheter (if urethra intact) OR suprapubic catheter (if urethral injury)

5. Faecal Diversion:

• Defunctioning loop colostomy if:
  • Anorectal source
  • Extensive perineal debridement
  • Faecal contamination risk
• Improves wound healing, reduces mortality

6. Testicular Management:

• Testes usually viable (separate blood supply)
• Remove necrotic scrotal skin
• Place testes in subcutaneous thigh pouches OR leave exposed (cover with moist dressings)
• Orchidectomy ONLY if non-viable

7. Wound Management:

• Leave wound OPEN (no primary closure)
• Pack with saline-soaked gauze OR apply negative pressure wound therapy (VAC)

8. Plan for Serial Debridement:

• Return to theatre in 24-48 hours (second-look mandatory)
• Continue serial debridements until NO further necrosis
• Average 3-5 operations

Post-operative:

• ICU for organ support
• Continue broad-spectrum antibiotics
• Adjust based on intraoperative cultures

Key Message: Adequate initial debridement and planned serial debridement are life-saving. Do NOT under-debride.

---

References

Systematic Reviews and Landmark Studies

1. Eke N. Fournier's gangrene: a review of 1726 cases. Br J Surg. 2000;87(6):718-728. PMID: 10848848

2. Singh A, Ahmed K, Aydin A, Khan MS, Dasgupta P. Fournier's gangrene: a clinical review. Arch Ital Urol Androl. 2016;88(3):157-164. PMID: 27711086

3. Sorensen MD, Krieger JN, Rivara FP, et al. Fournier's gangrene: population based epidemiology and outcomes. J Urol. 2009;181(5):2120-2126. PMID: 19286199

Severity Scoring Systems

4. Brook I, Frazier EH. Clinical and microbiological features of necrotizing fasciitis. J Clin Microbiol. 1995;33(9):2382-2387. PMID: 7494026

5. Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535-1541. PMID: 15286537

6. Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI. Outcome prediction in patients with Fournier's gangrene. J Urol. 1995;154(1):89-92. PMID: 7776464

Surgical Management

7. Czymek R, Frank P, Limmer S, et al. Fournier's gangrene: is the female gender a risk factor? Langenbecks Arch Surg. 2010;395(2):173-180. PMID: 19590890

8. Mallikarjuna MN, Vijayakumar A, Patil VS, Shivswamy BS. Fournier's gangrene: current practices. ISRN Surg. 2012;2012:942437. PMID: 22611494

9. Yeniyol CO, Suelozgen T, Arslan M, Ayder AR. Fournier's gangrene: experience with 25 patients and use of Fournier's gangrene severity index score. Urology. 2004;64(2):218-222. PMID: 15302463

Imaging and Diagnosis

10. Rajan DK, Scharer KA. Radiology of Fournier's gangrene. AJR Am J Roentgenol. 1998;170(1):163-168. PMID: 9423625

11. Corcoran AT, Smaldone MC, Gibbons EP, Walsh TJ, Davies BJ. Validation of the Fournier's gangrene severity index in a large contemporary series. J Urol. 2008;180(3):944-948. PMID: 18635211

Critical Care and Outcomes

12. Thwaini A, Khan A, Malik A, et al. Fournier's gangrene and its emergency management. Postgrad Med J. 2006;82(970):516-519. PMID: 16891442

13. Ozturk E, Ozguc H, Yilmazlar T. The use of vacuum assisted closure therapy in the management of Fournier's gangrene. Am J Surg. 2009;197(5):660-665. PMID: 18789428

14. Korhonen K. Hyperbaric oxygen therapy in acute necrotizing infections with a special reference to the effects on tissue gas tensions. Ann Chir Gynaecol Suppl. 2000;214:7-36. PMID: 11057808

Microbiology

15. Anaya DA, Bulger EM, Kwon YS, Kao LS, Evans H, Nathens AB. Predicting death in necrotizing soft tissue infections: a clinical score. Surg Infect (Larchmt). 2009;10(6):517-522. PMID: 19708769

Special Populations and Risk Factors

16. Chennamsetty A, Khourdaji I, Burks F, Killinger KA. Contemporary diagnosis and management of Fournier's gangrene. Ther Adv Urol. 2015;7(4):203-215. PMID: 26425142

17. Bjurlin MA, O'Grady T, Kim DY, Divakaruni N, Drago A, Blumetti J, Hollowell CM. Causative pathogens, antibiotic sensitivity, resistance patterns, and severity in a contemporary series of Fournier's gangrene. Urology. 2013;81(4):752-758. PMID: 23295174

Reconstruction

18. Karian LS, Chung SY, Lee ES. Reconstruction of defects after Fournier gangrene: a systematic review. Eplasty. 2015;15:e18. PMID: 25987981

Recent Guidelines and Consensus

19. Hakkarainen TW, Kopari NM, Pham TN, Evans HL. Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes. Curr Probl Surg. 2014;51(8):344-362. PMID: 25069713

20. Levenson RB, Singh AK, Novelline RA. Fournier gangrene: role of imaging. Radiographics. 2008;28(2):519-528. PMID: 18349454

---

Document Information

• Last Updated: 2026-01-08
• Evidence Level: High (systematic reviews, large case series, validation studies)
• Citations: 20 PubMed-indexed references
• Target Examinations: MRCS, FRCS (Urology/General Surgery), MRCP, Emergency Medicine postgraduate exams
• Difficulty: High (surgical emergency, high mortality, complex multi-disciplinary management)

---